{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:09:43Z","timestamp":1793383783717,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No 81500172"],"award-info":[{"award-number":["No 81500172"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No 81202962"],"award-info":[{"award-number":["No 81202962"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00432-020-03398-1","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T20:03:00Z","timestamp":1601409780000},"page":"3123-3135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Prognostic role of regulatory T cells in lymphoma: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"146","author":[{"given":"Fei","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shidai","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2815-4568","authenticated-orcid":false,"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"3398_CR1","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1186\/s12885-018-5086-y","volume":"18","author":"L Ai","year":"2018","unstructured":"Ai L, Mu S, Wang Y, Wang H, Cai L, Li W, Hu Y (2018) Prognostic role of myeloid-derived suppressor cells in cancers: a systematic review and meta-analysis. BMC Cancer 18:1220. https:\/\/doi.org\/10.1186\/s12885-018-5086-y","journal-title":"BMC Cancer"},{"key":"3398_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-019-1011-5","volume":"18","author":"L Ai","year":"2019","unstructured":"Ai L et al (2019) Myeloid-derived suppressor cells endow stem-like qualities to multiple myeloma cells by inducing piRNA-823 expression and DNMT3B activation. Mol Cancer 18:88. https:\/\/doi.org\/10.1186\/s12943-019-1011-5","journal-title":"Mol Cancer"},{"key":"3398_CR3","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1200\/jco.2006.05.9584","volume":"24","author":"GJ Bates","year":"2006","unstructured":"Bates GJ, Fox SB, Han C, Leek RD, Garcia JF, Harris AL, Banham AH (2006) Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 24:5373\u20135380. https:\/\/doi.org\/10.1200\/jco.2006.05.9584","journal-title":"J Clin Oncol"},{"key":"3398_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/bjh.14201","volume":"175","author":"YN Blaker","year":"2016","unstructured":"Blaker YN et al (2016) The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era. Br J Haematol 175:102\u2013114. https:\/\/doi.org\/10.1111\/bjh.14201","journal-title":"Br J Haematol"},{"key":"3398_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1309\/l65gweq803pp6vx1","volume":"130","author":"I Bonzheim","year":"2008","unstructured":"Bonzheim I et al (2008) Evaluation of FoxP3 expression in peripheral T cell lymphoma. Am J Clin Pathol 130:613\u2013619. https:\/\/doi.org\/10.1309\/l65gweq803pp6vx1","journal-title":"Am J Clin Pathol"},{"key":"3398_CR6","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","volume":"110","author":"G Borsellino","year":"2007","unstructured":"Borsellino G et al (2007) Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110:1225\u20131232. https:\/\/doi.org\/10.1182\/blood-2006-12-064527","journal-title":"Blood"},{"key":"3398_CR7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.immuni.2007.08.014","volume":"27","author":"X Cao","year":"2007","unstructured":"Cao X, Cai SF, Fehniger TA, Song J, Collins LI, Piwnica-Worms DR, Ley TJ (2007) Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27:635\u2013646. https:\/\/doi.org\/10.1016\/j.immuni.2007.08.014","journal-title":"Immunity"},{"key":"3398_CR8","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1182\/blood-2006-04-018218","volume":"108","author":"J Carreras","year":"2006","unstructured":"Carreras J et al (2006) High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 108:2957\u20132964. https:\/\/doi.org\/10.1182\/blood-2006-04-018218","journal-title":"Blood"},{"key":"3398_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3960\/jslrt.19003","volume":"59","author":"J Carreras","year":"2019","unstructured":"Carreras J et al (2019) High TNFRSF14 and low BTLA are associated with poor prognosis in follicular lymphoma and in diffuse large B cell lymphoma transformation. J Clin Exp Hematopathol 59:1\u201316. https:\/\/doi.org\/10.3960\/jslrt.19003","journal-title":"J Clin Exp Hematopathol"},{"key":"3398_CR10","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1097\/qad.0000000000000780","volume":"29","author":"C Chao","year":"2015","unstructured":"Chao C et al (2015) Stromal immune infiltration in HIV-related diffuse large B cell lymphoma is associated with HIV disease history and patient survival. Aids 29:1943\u20131951. https:\/\/doi.org\/10.1097\/qad.0000000000000780","journal-title":"Aids"},{"key":"3398_CR11","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1182\/blood-2008-07-168096","volume":"113","author":"B Chetaille","year":"2009","unstructured":"Chetaille B et al (2009) Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome. Blood 113:2765\u20133775. https:\/\/doi.org\/10.1182\/blood-2008-07-168096","journal-title":"Blood"},{"key":"3398_CR12","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942\u2013949. https:\/\/doi.org\/10.1038\/nm1093","journal-title":"Nat Med"},{"key":"3398_CR13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634. https:\/\/doi.org\/10.1136\/bmj.315.7109.629","journal-title":"BMJ"},{"key":"3398_CR14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/PAI.0000000000000335","volume":"25","author":"MMS El-Dien","year":"2017","unstructured":"El-Dien MMS, Abdou AG, Asaad NY, Abd El-Wahed MM, Kora MAE-HM (2017) Intratumoral FOXP3+regulatory T cells in diffuse large B cell lymphoma. Appl Immunohistochem Mol Morphol 25:534\u2013542","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"Suppl 8","key":"3398_CR15","doi-asserted-by":"publisher","first-page":"viii6","DOI":"10.1093\/annonc\/mds256","volume":"23","author":"OJ Finn","year":"2012","unstructured":"Finn OJ (2012) Immuno\u2013oncology: understanding the function and dysfunction of the immune system in cancer. Ann Oncol 23(Suppl 8):viii6\u20139. https:\/\/doi.org\/10.1093\/annonc\/mds256","journal-title":"Ann Oncol"},{"key":"3398_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/2326-6066.Cir-16-0297","volume":"5","author":"DI Gabrilovich","year":"2017","unstructured":"Gabrilovich DI (2017) Myeloid-derived suppressor cells. Cancer Immunol Res 5:3\u20138. https:\/\/doi.org\/10.1158\/2326-6066.Cir-16-0297","journal-title":"Cancer Immunol Res"},{"key":"3398_CR17","doi-asserted-by":"publisher","first-page":"85764","DOI":"10.18632\/oncotarget.7969","volume":"7","author":"C Giallongo","year":"2016","unstructured":"Giallongo C et al (2016) Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC). Oncotarget 7:85764\u201385775. https:\/\/doi.org\/10.18632\/oncotarget.7969","journal-title":"Oncotarget"},{"key":"3398_CR18","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1038\/sj.leu.2404913","volume":"21","author":"LM Gjerdrum","year":"2007","unstructured":"Gjerdrum LM et al (2007) FOXP3+ regulatory T cells in cutaneous T cell lymphomas: association with disease stage and survival. Leukemia 21:2512\u20132518. https:\/\/doi.org\/10.1038\/sj.leu.2404913","journal-title":"Leukemia"},{"key":"3398_CR19","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/ajcp\/aqw034","volume":"145","author":"JC Gomez-Gelvez","year":"2016","unstructured":"Gomez-Gelvez JC, Salama ME, Perkins SL, Leavitt M, Inamdar KV (2016) Prognostic impact of tumor microenvironment in diffuse large B cell lymphoma uniformly treated with R-CHOP chemotherapy. Am J Clin Pathol 145:514\u2013523. https:\/\/doi.org\/10.1093\/ajcp\/aqw034","journal-title":"Am J Clin Pathol"},{"key":"3398_CR20","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1182\/blood-2012-08-448548","volume":"121","author":"GT G\u00f6rg\u00fcn","year":"2013","unstructured":"G\u00f6rg\u00fcn GT et al (2013) Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans. Blood 121:2975\u20132987. https:\/\/doi.org\/10.1182\/blood-2012-08-448548","journal-title":"Blood"},{"key":"3398_CR21","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1200\/JCO.2011.39.9881","volume":"31","author":"P Greaves","year":"2013","unstructured":"Greaves P et al (2013) Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome. J Clin Oncol 31:256\u2013262. https:\/\/doi.org\/10.1200\/JCO.2011.39.9881","journal-title":"J Clin Oncol"},{"key":"3398_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"key":"3398_CR23","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057\u20131061. https:\/\/doi.org\/10.1126\/science.1079490","journal-title":"Science"},{"key":"3398_CR24","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1309\/nb3947k383dj0lq2","volume":"128","author":"TW Kelley","year":"2007","unstructured":"Kelley TW, Pohlman B, Elson P, Hsi ED (2007) The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T\/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression. Am J Clin Pathol 128:958\u2013965. https:\/\/doi.org\/10.1309\/nb3947k383dj0lq2","journal-title":"Am J Clin Pathol"},{"key":"3398_CR25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.exphem.2005.11.008","volume":"34","author":"G Khan","year":"2006","unstructured":"Khan G (2006) Epstein-Barr virus, cytokines, and inflammation: a cocktail for the pathogenesis of Hodgkin's lymphoma? Exp Hematol 34:399\u2013406. https:\/\/doi.org\/10.1016\/j.exphem.2005.11.008","journal-title":"Exp Hematol"},{"key":"3398_CR26","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1093\/annonc\/mdp056","volume":"20","author":"WY Kim","year":"2009","unstructured":"Kim WY et al (2009) Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK\/T cell lymphoma. Ann Oncol 20:1688\u20131696. https:\/\/doi.org\/10.1093\/annonc\/mdp056","journal-title":"Ann Oncol"},{"key":"3398_CR27","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.2147\/CMAR.S244176","volume":"12","author":"ST Lam","year":"2020","unstructured":"Lam ST et al (2020) A new immunological prognostic model based on immunohistochemistry for extranodal natural killer\/T cell lymphoma patients after non-anthracycline-based chemotherapy. Cancer Manag Res 12:1981\u20131990. https:\/\/doi.org\/10.2147\/CMAR.S244176","journal-title":"Cancer Manag Res"},{"key":"3398_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/10428190701824536","volume":"49","author":"N-R Lee","year":"2008","unstructured":"Lee N-R et al (2008) Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B cell lymphoma at diagnosis. Leukemia Lymphoma 49:247\u2013256. https:\/\/doi.org\/10.1080\/10428190701824536","journal-title":"Leukemia Lymphoma"},{"key":"3398_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biocel.2017.03.003","volume":"87","author":"X Li","year":"2017","unstructured":"Li X, Lu P, Li B, Zhang W, Yang R, Chu Y, Luo K (2017) Interleukin 2 and interleukin 10 function synergistically to promote CD8(+) T cell cytotoxicity, which is suppressed by regulatory T cells in breast cancer. Int J Biochem Cell Biol 87:1\u20137. https:\/\/doi.org\/10.1016\/j.biocel.2017.03.003","journal-title":"Int J Biochem Cell Biol"},{"key":"3398_CR30","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1365-2567.2011.03439.x","volume":"133","author":"CA Lindqvist","year":"2011","unstructured":"Lindqvist CA et al (2011) Both CD4+ FoxP3+ and CD4+ FoxP3- T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro. Immunology 133:296\u2013306. https:\/\/doi.org\/10.1111\/j.1365-2567.2011.03439.x","journal-title":"Immunology"},{"key":"3398_CR31","first-page":"105","volume":"124","author":"J Lundberg","year":"2019","unstructured":"Lundberg J, Berglund D, Molin D, Kinch A (2019) Intratumoral expression of FoxP3-positive regulatory T cells in T cell lymphoma: no correlation with survival Upsala. J Med Sci 124:105\u2013110","journal-title":"J Med Sci"},{"key":"3398_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13045-019-0797-3","volume":"12","author":"M Lv","year":"2019","unstructured":"Lv M, Wang K, Huang XJ (2019) Myeloid-derived suppressor cells in hematological malignancies: friends or foes. J Hematol Oncol 12:105. https:\/\/doi.org\/10.1186\/s13045-019-0797-3","journal-title":"J Hematol Oncol"},{"key":"3398_CR33","doi-asserted-by":"publisher","first-page":"5010","DOI":"10.4049\/jimmunol.178.8.5010","volume":"178","author":"E Marinova","year":"2007","unstructured":"Marinova E, Han S, Zheng B (2007) Germinal center helper T cells are dual functional regulatory cells with suppressive activity to conventional CD4+ T cells. J Immunol 178:5010\u20135017. https:\/\/doi.org\/10.4049\/jimmunol.178.8.5010","journal-title":"J Immunol"},{"issue":"175\u2013198","key":"3398_CR34","doi-asserted-by":"publisher","first-page":"vii","DOI":"10.1016\/j.rcl.2008.03.005","volume":"46","author":"MJ Matasar","year":"2008","unstructured":"Matasar MJ, Zelenetz AD (2008) Overview of lymphoma diagnosis and management. Radiol Clin North Am 46(175\u2013198):vii. https:\/\/doi.org\/10.1016\/j.rcl.2008.03.005","journal-title":"Radiol Clin North Am"},{"key":"3398_CR35","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.humpath.2009.03.025","volume":"40","author":"S Muenst","year":"2009","unstructured":"Muenst S, Hoeller S, Dirnhofer S, Tzankov A (2009) Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival. Hum Pathol 40:1715\u20131722. https:\/\/doi.org\/10.1016\/j.humpath.2009.03.025","journal-title":"Hum Pathol"},{"key":"3398_CR36","doi-asserted-by":"publisher","first-page":"7983","DOI":"10.1002\/jcp.27553","volume":"234","author":"M Najafi","year":"2019","unstructured":"Najafi M, Farhood B, Mortezaee K (2019) Contribution of regulatory T cells to cancer: a review. J Cell Physiol 234:7983\u20137993. https:\/\/doi.org\/10.1002\/jcp.27553","journal-title":"J Cell Physiol"},{"key":"3398_CR37","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1182\/bloodadvances.2016000885","volume":"1","author":"S Nakayama","year":"2017","unstructured":"Nakayama S et al (2017) Infiltration of effector regulatory T cells predicts poor prognosis of diffuse large B cell lymphoma, not otherwise specified. Blood Adv 1:486\u2013493. https:\/\/doi.org\/10.1182\/bloodadvances.2016000885","journal-title":"Blood Adv"},{"key":"3398_CR38","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.3109\/10428194.2013.879713","volume":"55","author":"SJ Nam","year":"2014","unstructured":"Nam SJ, Go H, Paik JH, Kim TM, Heo DS, Kim CW, Jeon YK (2014) An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. Leuk Lymphoma 55:2466\u20132476. https:\/\/doi.org\/10.3109\/10428194.2013.879713","journal-title":"Leuk Lymphoma"},{"key":"3398_CR39","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1002\/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8","volume":"17","author":"MK Parmar","year":"1998","unstructured":"Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17:2815\u20132834. https:\/\/doi.org\/10.1002\/(sici)1097-0258(19981230)17:24<2815:aid-sim110>3.0.co;2-8","journal-title":"Stat Med"},{"key":"3398_CR40","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.7150\/ijbs.7.1027","volume":"7","author":"RJ Peng","year":"2011","unstructured":"Peng RJ et al (2011) Circulating and tumor-infiltrating Foxp3(+) regulatory T cell subset in Chinese patients with extranodal NK\/T cell lymphoma. Int J Biol Sci 7:1027\u20131036. https:\/\/doi.org\/10.7150\/ijbs.7.1027","journal-title":"Int J Biol Sci"},{"key":"3398_CR41","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.humpath.2010.08.015","volume":"42","author":"BG Richendollar","year":"2011","unstructured":"Richendollar BG, Pohlman B, Elson P, Hsi ED (2011) Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma. Hum Pathol 42:552\u2013557. https:\/\/doi.org\/10.1016\/j.humpath.2010.08.015","journal-title":"Hum Pathol"},{"issue":"237\u2013246","key":"3398_CR42","doi-asserted-by":"publisher","first-page":"e231","DOI":"10.1016\/j.jaci.2009.10.025","volume":"125","author":"S Ring","year":"2010","unstructured":"Ring S, Karakhanova S, Johnson T, Enk AH, Mahnke K (2010) Gap junctions between regulatory T cells and dendritic cells prevent sensitization of CD8(+) T cells. J Allergy Clin Immunol 125(237\u2013246):e231\u2013237. https:\/\/doi.org\/10.1016\/j.jaci.2009.10.025","journal-title":"J Allergy Clin Immunol"},{"key":"3398_CR43","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.4049\/jimmunol.1401434","volume":"194","author":"S Ring","year":"2015","unstructured":"Ring S et al (2015) Regulatory T cell-derived adenosine induces dendritic cell migration through the Epac-Rap1 pathway. J Immunol 194:3735\u20133744. https:\/\/doi.org\/10.4049\/jimmunol.1401434","journal-title":"J Immunol"},{"key":"3398_CR44","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/sj.leu.2403965","volume":"19","author":"G Roncador","year":"2005","unstructured":"Roncador G et al (2005) FOXP3, a selective marker for a subset of adult T cell leukaemia\/lymphoma. Leukemia 19:2247\u20132253. https:\/\/doi.org\/10.1038\/sj.leu.2403965","journal-title":"Leukemia"},{"key":"3398_CR45","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fimmu.2016.00216","volume":"7","author":"CM Rueda","year":"2016","unstructured":"Rueda CM, Jackson CM, Chougnet CA (2016) Regulatory T cell-mediated suppression of conventional T cells and dendritic cells by different cAMP intracellular pathways. Front Immunol 7:216. https:\/\/doi.org\/10.3389\/fimmu.2016.00216","journal-title":"Front Immunol"},{"key":"3398_CR46","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3892\/etm.2010.146","volume":"1","author":"M Saifi","year":"2010","unstructured":"Saifi M et al (2010) High ratio of interfollicular CD8\/FOXP3-positive regulatory T cells is associated with a high FLIPI index and poor overall survival in follicular lymphoma. Exp Therap Med 1:933\u2013938","journal-title":"Exp Therap Med"},{"key":"3398_CR47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/jjco\/hyz202","volume":"50","author":"E Saito","year":"2020","unstructured":"Saito E, Matsuoka J (2020) International comparison of Hodgkin and non-Hodgkin lymphoma incidence. Jpn J Clin Oncol 50:96\u201397. https:\/\/doi.org\/10.1093\/jjco\/hyz202","journal-title":"Jpn J Clin Oncol"},{"key":"3398_CR48","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/jnci\/djy088","volume":"110","author":"W Sauerbrei","year":"2018","unstructured":"Sauerbrei W, Taube SE, McShane LM, Cavenagh MM, Altman DG (2018) Reporting recommendations for tumor marker prognostic studies (REMARK): an abridged explanation and elaboration. J Natl Cancer Inst 110:803\u2013811. https:\/\/doi.org\/10.1093\/jnci\/djy088","journal-title":"J Natl Cancer Inst"},{"key":"3398_CR49","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41590-019-0346-9","volume":"20","author":"DV Sawant","year":"2019","unstructured":"Sawant DV et al (2019) Adaptive plasticity of IL-10(+) and IL-35(+) T(reg) cells cooperatively promotes tumor T cell exhaustion. Nat Immunol 20:724\u2013735. https:\/\/doi.org\/10.1038\/s41590-019-0346-9","journal-title":"Nat Immunol"},{"key":"3398_CR50","doi-asserted-by":"publisher","first-page":"15179","DOI":"10.1038\/srep15179","volume":"5","author":"B Shang","year":"2015","unstructured":"Shang B, Liu Y, Jiang SJ, Liu Y (2015) Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis. Sci Rep 5:15179. https:\/\/doi.org\/10.1038\/srep15179","journal-title":"Sci Rep"},{"key":"3398_CR51","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/s0140-6736(12)60605-9","volume":"380","author":"KR Shankland","year":"2012","unstructured":"Shankland KR, Armitage JO, Hancock BW (2012) Non-Hodgkin lymphoma. Lancet 380:848\u2013857. https:\/\/doi.org\/10.1016\/s0140-6736(12)60605-9","journal-title":"Lancet"},{"key":"3398_CR52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD (2020) Cancer statistics, 2020. CA Cancer J Clin 70:7\u201330. https:\/\/doi.org\/10.3322\/caac.21590","journal-title":"CA Cancer J Clin"},{"key":"3398_CR53","doi-asserted-by":"publisher","first-page":"39658","DOI":"10.18632\/oncotarget.17340","volume":"8","author":"L Sun","year":"2017","unstructured":"Sun L et al (2017) Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis. Oncotarget 8:39658\u201339672. https:\/\/doi.org\/10.18632\/oncotarget.17340","journal-title":"Oncotarget"},{"key":"3398_CR54","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3324\/haematol.11702","volume":"93","author":"A Tzankov","year":"2008","unstructured":"Tzankov A, Meier C, Hirschmann P, Went P, Pileri SA, Dirnhofer S (2008) Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica 93:193\u2013200. https:\/\/doi.org\/10.3324\/haematol.11702","journal-title":"Haematologica"},{"issue":"Suppl 1","key":"3398_CR55","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s10875-016-0268-3","volume":"36","author":"H Ueno","year":"2016","unstructured":"Ueno H (2016) Human circulating T follicular helper cell subsets in health and disease. J Clin Immunol 36(Suppl 1):34\u201339. https:\/\/doi.org\/10.1007\/s10875-016-0268-3","journal-title":"J Clin Immunol"},{"key":"3398_CR56","first-page":"1923","volume":"11","author":"C Wang","year":"2018","unstructured":"Wang C et al (2018) PD-1, FOXP3, and CSF-1R expression in patients with Hodgkin lymphoma and their prognostic value. Int J Clin Exp Pathol 11:1923\u20131934","journal-title":"Int J Clin Exp Pathol"},{"key":"3398_CR57","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3389\/fphys.2017.00950","volume":"8","author":"P Xu","year":"2017","unstructured":"Xu P, Fan W, Zhang Z, Wang J, Wang P, Li Y, Yu M (2017) The clinicopathological and prognostic implications of FoxP3(+) regulatory T cells in patients with colorectal cancer: a meta-analysis. Front Physiol 8:950. https:\/\/doi.org\/10.3389\/fphys.2017.00950","journal-title":"Front Physiol"},{"key":"3398_CR58","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1182\/blood-2005-11-4502","volume":"107","author":"DM Zhao","year":"2006","unstructured":"Zhao DM, Thornton AM, DiPaolo RJ, Shevach EM (2006) Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood 107:3925\u20133932. https:\/\/doi.org\/10.1182\/blood-2005-11-4502","journal-title":"Blood"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03398-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-020-03398-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03398-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:16:55Z","timestamp":1632874615000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-020-03398-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3398"],"URL":"https:\/\/doi.org\/10.1007\/s00432-020-03398-1","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]},"assertion":[{"value":"22 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared that no competing interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}